Mount Sinai Researchers Develop First Targeted Therapy for Rare T-Cell Lymphoma Following CAR T Treatment
In a landmark development at the forefront of hematologic oncology, researchers from The Tisch Cancer Institute at the Icahn School ...
In a landmark development at the forefront of hematologic oncology, researchers from The Tisch Cancer Institute at the Icahn School ...
New Insights from Memorial Sloan Kettering Illuminate Immune Defenses, CAR T Cell Side Effects, Metabolic Profiling, and CRISPR Antiviral Mechanisms ...
In the evolving landscape of cancer treatment, particularly concerning hematological malignancies such as multiple myeloma and lymphoma, Car-T cell therapy ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine